Area of research
Urology · Rheumatology
Research interest
Research focused on Overactive bladder and Mirabegron, with related work in Urinary incontinence, Lower urinary tract symptoms, Urology. Notable publications include 'A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment', 'Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis', and 'Randomized Double-blind, Active-controlled Phase 3 Study to Assess 12-Month Safety and Efficacy of Mirabegron, a β3-Adrenoceptor Agonist, in Overactive Bladder'.
From Clinical Trials to Routine Practice: Are Urodynamics Still Useful?
Vibegron in overactive bladder: a comprehensive review of efficacy, safety and patient-reported outcomes
Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021
European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era
A Systematic Review of Surgical interventions for the Treatment of Bladder Pain Syndrome/Interstitial Cystitis
Conservative management of urinary incontinence following robot-assisted radical prostatectomy
A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment
Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019
Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB)
Assessment of Electrospun and Ultra-lightweight Polypropylene Meshes in the Sheep Model for Vaginal Surgery
Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence
Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence
Can incontinence be cured? A systematic review of cure rates
Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms
Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysis
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
Evaluating Alternative Materials for the Treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse: A Comparison of the In Vivo Response to Meshes Implanted in Rabbits
The Underactive Bladder: A New Clinical Concept?
Cardiovascular Safety of β3-adrenoceptor Agonists for the Treatment of Patients with Overactive Bladder Syndrome
Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women
Bladder function after radical hysterectomy for cervical cancer
Safety and tolerability of the β<sub>3</sub>‐adrenoceptor agonist mirabegron, for the treatment of overactive bladder: results of a prospective pooled analysis of three 12‐week randomised Phase III trials and of a 1‐year randomised Phase III trial
Long-term Safety and Efficacy of Single-tablet Combinations of Solifenacin and Tamsulosin Oral Controlled Absorption System in Men with Storage and Voiding Lower Urinary Tract Symptoms: Results from the NEPTUNE Study and NEPTUNE II Open-label Extension
Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men
A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non‐neurogenic male lower urinary tract symptoms ( <scp>LUTS</scp> ) suggestive of benign prostatic hyperplasia ( <scp>BPH</scp> )
Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis
Mirabegron in overactive bladder: A review of efficacy, safety, and tolerability
An Updated Systematic Review and Statistical Comparison of Standardised Mean Outcomes for the Use of Botulinum Toxin in the Management of Lower Urinary Tract Disorders
Systematic Review of Combination Drug Therapy for Non-neurogenic Male Lower Urinary Tract Symptoms